Chronic disease patients relying on DarioHealth's mobile glucose management system will soon have in-app access to medical specialists, thanks to a new telemedicine integration with MediOrbis' MySpecialistMD network.
According to an announcement from the companies released yesterday, the virtual services now on offer through the app include primary and acute care; chronic disease management for conditions such as diabetes, hypertension and COPD; and specialty consultations or second opinions for more complicated medical concerns.
These telehealth features come alongside DarioHealth's core system: a disease-tracking and management app, as well as a connected phone attachment housing a lancing device, glucose meter and a testing-strip holder.
“We are pleased to be able to deploy our industry-leading physician network and telehealth platform to help those most at risk for complications from COVID-19 due to chronic illness like diabetes and hypertension,” Dr. Jonathan Wiesen, founder and CMO of MediOrbis, said in a statement. “Dario’s open architecture and user base allow us to make the greatest impact when patients suffering from chronic illness lack access to their regular healthcare providers.”
WHAT'S THE IMPACT?
DarioHealth wrote in its announcement that the deal and its resulting platform expansion were largely driven by COVID-19, which poses an even greater risk to those living with a chronic disease. The company sees MediOrbis' doctor network as a substantial value add for the 50,000 people it says are using its disease management platform.
“This partnership broadens Dario’s SaaS-based service offering by delivering on-demand access to physicians who can, not only help treat acute illness, but also provide care for chronic medical conditions such as diabetes and hypertension,” Rick Anderson, DarioHealth’s president and general manager, said in a statement. “As we seek complementary offerings to create complete business-to-business healthcare solutions for remote care, now in high demand and perhaps the future standard, we believe we have a strong partner in MediOrbis.”
THE LARGER TREND
The COVID-19 has led a large number of health stakeholders to reconsider their stance on telehealth and remote care – and in doing so, opened the door for digital health platforms looking to expand. Hims, for instance, has pushed its business further into telehealth with virtual primary and behavioral care, while telehealth platforms like Medici, Tyto Care, SteadyMD and 98point6 have all announced new funding rounds within the last handful of weeks.
